First Allied Advisory Services’s Haemonetics HAE Stock Holding History

First Allied Advisory Services’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,799	Closed	-$220K	–	1282
2017 Q4	$220K	Buy	+3,799	New	+$200K	0.01%	1006
2017 Q3	–	Sell	-8,091	Closed	-$316K	–	1152
2017 Q2	$316K	Buy	+8,091	New	+$332K	0.01%	800
2016 Q2	–	Sell	-5,770	Closed	-$204K	–	1062
2016 Q1	$204K	Buy	+5,770	New	+$186K	0.01%	904
2015 Q3	–	Sell	-5,737	Closed	-$235K	–	1083
2015 Q2	$235K	Sell	5,737 -259	-4%	-$10.9K	0.01%	937
2015 Q1	$274K	Sell	5,996 -34	-0.6%	-$1.42K	0.02%	818
2014 Q4	$229K	Buy	6,030 +93	+2%	+$3.41K	0.02%	879
2014 Q3	$215K	Buy	+5,937	New	+$212K	0.02%	888

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

First Allied Advisory Services's HAE Position: Q1 2018 in Review

First Allied Advisory Services sold out of Haemonetics (HAE) in Q1 2018, closing a stake of 3,799 shares — an estimated $220K sold.

First Allied Advisory Services first reported a position in HAE in Q3 2014 and held it in 7 quarters. The position peaked at $316K in Q2 2017. 261 funds tracked by Wall St. Rank hold HAE as of Q1 2018.

First Allied Advisory Services reported no remaining Haemonetics position as of Q1 2018 after selling out during the quarter.
First Allied Advisory Services sold 3,799 Haemonetics shares in Q1 2018, an estimated $220K.
First Allied Advisory Services first reported a position in Haemonetics in Q3 2014 and held it in 7 quarters.
First Allied Advisory Services's Haemonetics position peaked at $316K in Q2 2017.
261 funds tracked by Wall St. Rank held Haemonetics as of Q1 2018.

Based on First Allied Advisory Services's 13F filing for Q1 2018, filed 11 May 2018.